These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Treatment of raynaud's disease and phenomenon with intraarterial reserpine (author's transl)]. González Folch M; Saffie F Rev Med Chil; 1976 Jan; 104(1):21-4. PubMed ID: 788084 [No Abstract] [Full Text] [Related]
9. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control]. Dumoulin J Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383 [No Abstract] [Full Text] [Related]
10. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker. Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173 [No Abstract] [Full Text] [Related]
11. [Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study]. Madsen JL; Hvidt S Ugeskr Laeger; 1984 Sep; 146(36):2695-7. PubMed ID: 6393495 [No Abstract] [Full Text] [Related]
12. A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon. Holti G Practitioner; 1982 Apr; 226(1366):781-3. PubMed ID: 7045853 [No Abstract] [Full Text] [Related]
14. [A double-blind clinical trial of a topical preparation with a base of biochemical precursors of glucosaminoglycan (GAG) in patients suffering from Raynaud's disease]. Signorini GP Boll Chim Farm; 1986 Oct; 125(10):103S-110S. PubMed ID: 3551995 [No Abstract] [Full Text] [Related]
15. Prevalence of Raynaud's phenomenon in a healthy Spanish population. Riera G; Vilardell M; Vaqué J; Fonollosa V; Bermejo B J Rheumatol; 1993 Jan; 20(1):66-9. PubMed ID: 8441168 [TBL] [Abstract][Full Text] [Related]
16. [Raynaud's disease and syndromes]. Montorsi W Minerva Med; 1974 Nov; 65(78):4087-111. PubMed ID: 4431575 [No Abstract] [Full Text] [Related]
17. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Fries R; Shariat K; von Wilmowsky H; Böhm M Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885 [TBL] [Abstract][Full Text] [Related]
18. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease]. Acevedo A; Palacios JM; López R; Palma F Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168 [No Abstract] [Full Text] [Related]
19. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon. Pisenti L; Hart LL Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494 [No Abstract] [Full Text] [Related]